Ms. Isabelle Tremblay joins the board of directors of Pharma in silica

Quebec City, December 28, 2022 - The Board of Directors of Pharma in silica Laboratories has expanded to seven members with the addition of Ms. Isabelle Tremblay, MBA.

National Field Market Access Lead at AbbVie, she brings to Pharma in silica over 20 years of experience in the pharmaceutical industry. The individual investors co-opted her to their third board positions. Ms. Tremblay sits as an individual.

About Pharma in silica inc.

Laboratoires Pharma in silica inc. is a preclinical-stage pharmaceutical company based in Québec City's Parc Technologique. Since 2019, it has been developing novel treatments for solid cancers (lung, breast, etc.) using OpPacli™, a patented drug nanocarrier. The company is driven by a dynamic group of chemists, pharmacists and managers led by François Arcand, an experienced life sciences entrepreneur (Medicago, Conferences on Plant-made Pharmaceuticals, ERA Biotech). The company established its own research and production facilities and collaborates with oncology experts and world-renowned research centers and has completed the pre-IND/CTA meetings with the FDA and Health Canada.

For more information

François Arcand
President, Pharma in silica inc
514 994 1023 / 418 874-0054 #233
info@pharma-insilica.com

> all news